Average Co-Inventor Count = 6.04
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Aeterna Zentaris Gmbh (11 from 36 patents)
2. Zentaris Gmbh (2 from 22 patents)
3. Æterna Zentaris Gmbh (2 patents)
13 patents:
1. 8937068 - Pyridopyrazine derivatives and their use
2. 8912189 - Pyridopyrazine derivatives and their use
3. 8791118 - Pyridopyrazines as highly selective ras-Raf-Mek-Erk signal transduction pathway inhibitors
4. 8604196 - Modulating signal transduction pathways with 1-ethyl-3-[3-(1-methyl-1H-pyrazol-4-yl)-pyrido[2.3-B]pyrazine-6-yl]thiourea
5. 8536332 - Modulating signal transduction pathways with substituted pyridol [2,3-b] pyrazines
6. 8507486 - Pyridopyrazine derivatives, process of manufacturing and uses thereof
7. 8461178 - Naphthyridine derivatives and the use thereof as kinase inhibitors
8. 8394801 - Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
9. 8217042 - Pyridopyrazines and their use as modulators of kinases
10. 8202883 - Substituted pyrido[2,3-b]pyrazine compounds as modulators of tyrosine kinases
11. 8193186 - Pyridopyrazines and the use thereof as kinase inhibitors
12. 7323468 - Pyridopyrazines and the use thereof as kinase inhibitors
13. 7276507 - Pyridopyrazines and the use thereof as kinase inhibitors